UK markets closed

180 Life Sciences Corp. (ATNF)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0000+0.0300 (+1.52%)
At close: 04:00PM EDT
2.0000 0.00 (0.00%)
After hours: 07:34PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-15,948
-19,935
-38,726
-20,325
-10,884
Depreciation & amortisation
88.204
105.675
109.004
109.947
125.333
Deferred income taxes
-8.216
-2,350
-942.749
-24.803
-20.427
Stock-based compensation
2,984
2,194
2,634
2,852
1,118
Change in working capital
-667.302
-14.104
2,723
-8,807
2,332
Accounts payable
368.018
286.41
1,215
-5,731
2,227
Other working capital
-14,228
-10,922
-12,128
-19,371
-3,872
Other non-cash items
321.143
89.189
331.591
1,231
717.666
Net cash provided by operating activities
-14,228
-10,922
-12,128
-19,371
-3,872
Cash flows from investing activities
Other investing activities
-
-
-
-
11,484
Net cash used for investing activities
-
-
-
0
14,491
Cash flows from financing activities
Debt repayment
-1,561
-1,257
-1,672
-817.594
-72.843
Common stock issued
6,500
5,999
12,500
26,666
72.5
Common stock repurchased
0
0
-1,015
0
-9,006
Other financing activities
-529.982
195.953
-
-2,055
-201.859
Net cash used provided by (used for) financing activities
6,027
5,908
10,874
25,412
-8,734
Net change in cash
-8,099
-4,994
-1,254
6,116
2,025
Cash at beginning of period
11,688
6,970
8,225
2,109
83.397
Cash at end of period
3,486
1,976
6,970
8,225
2,109
Free cash flow
Operating cash flow
-14,228
-10,922
-12,128
-19,371
-3,872
Free cash flow
-14,228
-10,922
-12,128
-19,371
-3,872